| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/22/2001 | WO2000010600A9 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents |
| 11/22/2001 | US20010044524 Method for preparing dual virally inactivated immune globulin for intravenous administration |
| 11/22/2001 | US20010044122 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 11/22/2001 | US20010043953 Antiviral agent and method of producing the same |
| 11/22/2001 | US20010043952 Anti-oxidant reducing substance and method of producing the same |
| 11/22/2001 | US20010043933 Exposing bacteria culture to stress, separating the medium and stress response product from the bacteria, and filtering the separated product to form a filtrate, administering the filtrate to an animal; vaccine adjuvants, treat endotoxemia |
| 11/22/2001 | US20010043927 Method for producing a nematocidal composition by heat treating a pH-adjusted fermentation broth |
| 11/22/2001 | US20010043923 Controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface; in vivo implantation |
| 11/22/2001 | US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination |
| 11/22/2001 | US20010043919 Proliferation of hepatocyte precursors |
| 11/22/2001 | US20010043917 Bacteriophage modified by serial passageing or genetic engineering so the modified bacteriophage will remain active in the body for a longer time than the wild-type phage; infections |
| 11/22/2001 | CA2409452A1 Methods for enriching for quiescent cells in hematopoietic cell populations |
| 11/22/2001 | CA2409448A1 Methods for modulating the proliferation of hematopoietic cells |
| 11/22/2001 | CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 11/22/2001 | CA2409141A1 Method for preventing allograft rejection |
| 11/22/2001 | CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators |
| 11/22/2001 | CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells |
| 11/22/2001 | CA2408756A1 Immune potentiating compositions |
| 11/22/2001 | CA2408701A1 Compositions and methods for tissue dedifferentiation and regeneration |
| 11/22/2001 | CA2408530A1 Novel deoxynucleoside kinase enzyme variants |
| 11/22/2001 | CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors |
| 11/22/2001 | CA2407104A1 Method to increase class i presentation of exogenous antigens by human dendritic cells |
| 11/22/2001 | CA2404822A1 Fertilization of aged oocytes |
| 11/21/2001 | EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 11/21/2001 | EP1156067A2 (Meth)Acrylic Copolymers comprising glycolether and aminoalkyl units and blood filter using the same |
| 11/21/2001 | EP1155136A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
| 11/21/2001 | EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes |
| 11/21/2001 | EP1155118A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of somatic cells |
| 11/21/2001 | EP1155115A1 Method of modifying cytotoxic cells and uses thereof |
| 11/21/2001 | EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 11/21/2001 | EP1154801A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 11/21/2001 | EP1154780A2 Bone marrow transplantation for hepatic regeneration and repair |
| 11/21/2001 | EP1154734A1 Injectable collagen-based system for delivery of cells or therapeutic agents |
| 11/21/2001 | EP1154692A1 A method of controlling fungal pathogens, and agents useful for same |
| 11/21/2001 | EP1154686A1 Method for inhibiting transplant rejection |
| 11/21/2001 | EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 11/21/2001 | EP0708674B1 Blood collection system |
| 11/21/2001 | CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 11/21/2001 | CN1323228A Methods instruments and materials for chondrocyte cell transplantation |
| 11/21/2001 | CN1323181A Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 11/21/2001 | CN1322761A Animal hematoglobin and its extraction process and use |
| 11/21/2001 | CN1322577A Apparatus for producing fibrin adhesive & the like blood products and its medical use |
| 11/21/2001 | CN1322574A Insulin B chain gene vaccine prepn |
| 11/21/2001 | CN1322566A Medicine for treating stomatopathy and throat disease |
| 11/21/2001 | CN1322560A Chinese medicine preparation for treating leukoderma and its preparation |
| 11/21/2001 | CN1322558A Liver cancer resisting medicine |
| 11/21/2001 | CN1322557A Medicine for treating cardiac and cerebral vascular disease and hypertension and its preparation process |
| 11/21/2001 | CN1322556A Chinese medicine preparation for treating rheumatism and rheumatoid disease |
| 11/21/2001 | CN1322553A Medicine for treating hyperosteogeny and protrusion of lumber intervertebral disc and its preparation |
| 11/21/2001 | CN1322548A Recipe and preparation process of skin itching and pain treating liquid |
| 11/21/2001 | CN1322544A External-use Chinese medicine for treating dermatosis |
| 11/21/2001 | CN1322542A Preparation of external-use medicine for mastoproliferation |
| 11/21/2001 | CN1322536A Laxative and its preparation |
| 11/21/2001 | CN1322535A Recipe and preparation of hot compressing Chinese herbal medicine |
| 11/21/2001 | CN1322532A Application of staphyococcin Aureus in preparing medicine for osteoporosis |
| 11/21/2001 | CN1322531A Balancing antiinflame agent |
| 11/21/2001 | CN1074930C Tongshuanhuoluowan-medicine for thrombolysis and activating collaterals |
| 11/21/2001 | CN1074929C Chilblain paste |
| 11/21/2001 | CN1074928C Medicine for curing hemiplegia and its preparing process |
| 11/21/2001 | CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same |
| 11/21/2001 | CN1074914C Health nutrient powder containing scorpion extract and its product |
| 11/20/2001 | US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors |
| 11/20/2001 | US6319703 Recombinant virus vectors |
| 11/20/2001 | US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene |
| 11/20/2001 | US6319666 Treating humans for viral infections; incubate human with antigen, monitor immunological response, screen for presence of viral proteins |
| 11/20/2001 | US6319662 Method and apparatus for removing viral contaminants from a body fluid |
| 11/20/2001 | US6319522 Growth-promoting agent |
| 11/20/2001 | US6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof |
| 11/20/2001 | US6319495 Method for restoring glucose responsiveness to insulin secretion |
| 11/20/2001 | US6319392 Thin film evaporation and distillation |
| 11/20/2001 | US6319192 Method for the treatment of fertility disorders |
| 11/20/2001 | CA2018287C Use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection, and composition for inhibiting transplant rejection |
| 11/15/2001 | WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
| 11/15/2001 | WO2001085980A2 Enzymatic assays for screening anti-cancer agents |
| 11/15/2001 | WO2001085974A2 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 11/15/2001 | WO2001085960A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy |
| 11/15/2001 | WO2001085953A1 Sphingosine kinase and uses thereof |
| 11/15/2001 | WO2001085938A1 Modified es cells and es cell-specific gene |
| 11/15/2001 | WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 11/15/2001 | WO2001085917A2 A device |
| 11/15/2001 | WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 11/15/2001 | WO2001085779A2 Protein complexes and assays for screening anti-cancer agents |
| 11/15/2001 | WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents |
| 11/15/2001 | WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 11/15/2001 | WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/15/2001 | WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/15/2001 | WO2001085187A1 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders |
| 11/15/2001 | WO2001085186A1 Preparation that contains the intestinal beneficial bacterium fermentation culture |
| 11/15/2001 | WO2001085185A2 Treatment of il-10 deficiencies |
| 11/15/2001 | WO2001085184A2 Nontoxic vernix compositions and method of producing |
| 11/15/2001 | WO2001085183A2 Preparation for the prevention and treatment of ocular disorders |
| 11/15/2001 | WO2001085182A2 Combined cartilage and plant extract compositions |
| 11/15/2001 | WO2001085161A1 Combination preparation consisting of φ-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs |
| 11/15/2001 | WO2001085128A2 Skin protectant spray compositions |
| 11/15/2001 | WO2001084963A1 Edible composition containing micronised nacre powder |
| 11/15/2001 | WO2001084933A1 A homeodomain protein code specifying progenitor cell identity and neuronal fate in the ventral neural tube |
| 11/15/2001 | WO2001047535A3 Pharmaceutical composition comprising snake venom and method for its manufacture |
| 11/15/2001 | WO2001047373A8 Honey based food product for relief of stomach and intestine complaints and compressed product comprising said composition |
| 11/15/2001 | WO2001019974A3 Recombinant microorganisms |
| 11/15/2001 | WO2001009616A3 Method for determining physiological effects of hemoglobin |